Trial Search Results

Characteristics of Adult Patients With Recessive Dystrophic Epidermolysis Bullosa

Recessive dystrophic epidermolysis bullosa (RDEB) is a severe inherited blistering disease caused by the absence of type VII collagen. Patients with RDEB develop large, severely painful blisters and open wounds from minor trauma to their skin. We are screening RDEB subjects to determine additional characteristics of patients who survive to adulthood.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Eligibility


Inclusion Criteria:1. Clinical diagnosis of RDEB by local dermatologist. 2. 18 years of age
or more and willing to give consent.

Exclusion Criteria:1. Medical instability limiting ability to travel to Stanford University
Medical Center.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Emily Gorell, MS
650-721-7166
Not Recruiting